Related Experiment Videos
A chick embryo model for metastatic human prostate cancer
T Kobayashi1, K Koshida, Y Endo
1Department of Urology, School of Medicine, Kanazawa University, Kanazawa, Japan.
European Urology
|August 7, 1998
Summary
This study developed a chick embryo model for human prostate cancer bone and liver micrometastases. The model effectively evaluated antitumor agents, showing suramin
Area of Science:
- Oncology
- Translational Research
- Animal Models
Background:
- Prostate cancer commonly metastasizes to bone and liver.
- Developing reliable models for studying prostate cancer metastasis is crucial for therapeutic development.
Purpose of the Study:
- To establish a reproducible chick embryo model for human prostate cancer bone and liver micrometastases.
- To utilize this model for evaluating the efficacy of antitumor agents.
Main Methods:
- PC-3 human prostate cancer cells were inoculated into chick embryos.
- Polymerase chain reaction and immunohistochemistry were used to detect and quantify micrometastases.
- The antitumor effects of suramin were assessed, along with regional blood flow.
Main Results:
- Micrometastases were detected in bone and liver within 1 day post-inoculation.
- Suramin demonstrated significant efficacy against liver micrometastases.
- Bone micrometastases showed less response to suramin, correlating with lower blood flow.
Conclusions:
- The chick embryo system is a highly reproducible model for studying prostate cancer bone and liver micrometastases.
- This model is suitable for early-stage evaluation of antineoplastic agents.
- Differential drug response in bone versus liver metastases highlights the importance of vascularization.